Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
Open Biology|June 13, 2014
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complexEyal Greenberg, Steven Hajdu, Yael Nemlich, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2018
Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40Noam Levin, Hadas Weinstein-Marom, Aviad Pato, et al.Cancer Immunology, Immunotherapy : CII|June 30, 2019
Reduced CTL motility and activity in avascular tumor areasYoav Manaster, Zohar Shipony, Anat Hutzler, et al.Cancer Immunology, Immunotherapy : CII|May 31, 2018
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patientsRonny Ben-Avi, Ronit Farhi, Alon Ben-Nun, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 3, 2012
Ras oncoproteins transfer from melanoma cells to T cells and modulate their effector functionsHelly Vernitsky, Oded Rechavi, Nir Rainy, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 17, 2020
Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patientsDaphna Hutt, Bella Bielorai, Bella Baturov, et al.Bone Marrow Transplantation|February 28, 2019
Early and late hematologic toxicity following CD19 CAR-T cellsShalev Fried, Abraham Avigdor, Bella Bielorai, et al.Immunology|June 19, 2008
Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attackGal Markel, Rachel Seidman, Yifat Cohen, et al.Frontiers in Oncology|October 24, 2022
Impact of cryopreservation on CAR T production and clinical responseKarin Brezinger-Dayan, Orit Itzhaki, Jenny Melnichenko, et al.Leukemia & Lymphoma|February 10, 2021
Characteristics and risk factors of infections following CD28-based CD19 CAR-T cellsTalya Wittmann Dayagi, Gilad Sherman, Bella Bielorai, et al.Pageof 8